FDA Drug Approval, N010401, MYSOLINE
FDA Drug Approval, N010401, MYSOLINE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 010401
Company: FHTA
Drug Name: MYSOLINE
Active Ingredients: PRIMIDONE
Strength: SUSPENSION;ORAL
Dosage Form/Route: Discontinued
Action Date: ORIG-1
Marketing Status: None
Submission Classification: STANDARD
Company: FHTA
Drug Name: MYSOLINE
Active Ingredients: PRIMIDONE
Strength: SUSPENSION;ORAL
Dosage Form/Route: Discontinued
Action Date: ORIG-1
Marketing Status: None
Submission Classification: STANDARD
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details